← Eichor
Condition: Stage Ib Iiib Nsclc Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Stage Ib Iiib Nsclc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuv
Phase 2 · 1 location(s) · Wen-zhao ZHONG · NCT07039656AK129 Combination Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Akeso · NCT06943820A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With St
Phase 3 · 2 location(s) · Allist Pharmaceuticals, Inc. · NCT07010419Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · Zhujiang Hospital · NCT07534033Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · Mayo Clinic · NCT06918132Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations
Phase 3 · 3 location(s) · Betta Pharmaceuticals Co., Ltd. · NCT06041776Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously
Phase 3 · 32 location(s) · Fundación GECP · NCT06431633Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cel
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT03948100Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03819296Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC
Phase 2 · 1 location(s) · Sichuan Cancer Hospital and Research Institute · NCT06532591Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer
Phase 3 · 1 location(s) · Betta Pharmaceuticals Co., Ltd. · NCT05341583
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.